Brief: HBM Holdings Says U.S. FDA IND Clearance For HBM1007 Clinical Trial Initiation
18/01/2023 23:46
Jan 19 (Reuters) - Hbm Holdings Ltd 2142.HK :
* FOOD AND DRUG ADMINISTRATION OF UNITED STATES IND
CLEARANCE FOR
HBM1007 CLINICAL TRIAL INITIATION
Further company coverage: 2142.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on HBM Holdings
See all newsBrief: HBM Holdings Says NMPA Approves Batoclimab Injection For Generalized Myasthenia Gravis
HBM climbs on development of AI biology foundation model
Brief: HBM Holdings' Unit Develops World's First Language Model For Fully Human Heavy-Chain-Only Antibodies
Brief: Hbm Holdings Says Solstice Oncology Launches Series A Financing Round
HK-listed HBM climbs on initiating next phase of asthma drug study